Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

Oxazepam - Generic Drug Details

« Back to Dashboard

What are the generic sources for oxazepam and what is the scope of patent protection?

Oxazepam
is the generic ingredient in three branded drugs marketed by Parke Davis, Mylan, Sandoz, Frontida Biopharm, Alpharma Us Pharms, Quantum Pharmics, Ivax Sub Teva Pharms, Actavis Elizabeth, Watson Labs, Am Therap, and Sun Pharm Inds, and is included in twenty-six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for oxazepam. Nine suppliers are listed for this compound.

Summary for Generic Name: oxazepam

Tradenames:3
Patents:1
Applicants:11
NDAs:26
Drug Master File Entries: see list8
Suppliers / Packagers: see list9
Bulk Api Vendors: see list19
Clinical Trials: see list4
Patent Applications: see list6,738
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:oxazepam at DailyMed

Pharmacology for Ingredient: oxazepam

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
OXAZEPAM
oxazepam
CAPSULE;ORAL071756-001Apr 19, 1988ABRXNoNo► Subscribe► Subscribe
Parke Davis
OXAZEPAM
oxazepam
TABLET;ORAL071508-001Feb 2, 1987DISCNNoNo► Subscribe► Subscribe
Alpharma Us Pharms
SERAX
oxazepam
CAPSULE;ORAL015539-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Actavis Elizabeth
OXAZEPAM
oxazepam
CAPSULE;ORAL072251-001Apr 14, 1988ABRXNoNo► Subscribe► Subscribe
Quantum Pharmics
ZAXOPAM
oxazepam
CAPSULE;ORAL070640-001Mar 1, 1988DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot